Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
about
SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracyNon-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future ProspectsNon-invasive prenatal testing: a review of international implementation and challengesRecent advances in prenatal genetic screening and testingNon-invasive prenatal detection of trisomy 13 using a single nucleotide polymorphism- and informatics-based approach.Novel Algorithms for Improved Sensitivity in Non-Invasive Prenatal Testing.Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohortValidation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusionAnalysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral centerBeyond Trisomy 21: Additional Chromosomal Anomalies Detected through Routine Aneuploidy Screening.Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.Prenatal diagnosis of a 46,XX male following noninvasive prenatal testing.Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS)Prenatal screening methods for aneuploidiesNon-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners.Second-generation non-invasive high-throughput DNA sequencing technology in the screening of Down's syndrome in advanced maternal age womenClinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies.IONA test for first-trimester detection of trisomies 21, 18 and 13.Commercial landscape of noninvasive prenatal testing in the United States.Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessment.Non-invasive prenatal testing for aneuploidy: current status and future prospects.Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.What does next-generation sequencing mean for prenatal diagnosis?Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNAThe implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon.Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors.Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test.Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.Obstetrical provider knowledge and attitudes towards cell-free DNA screening: results of a cross-sectional national survey.UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake.Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe.
P2860
Q24627800-2688AED0-9FEF-42F2-AC4F-58D4C7E6C4D3Q26827338-A8C38230-AB59-4EE5-91E9-3A8B6039B4D7Q26999426-CB6E6B5C-C7E5-4D0E-8D34-E0354C6F6A99Q28071888-EC812D45-6BB8-4214-907C-30C9C4EF00F1Q33578055-FD12BED8-439B-4D92-A759-53EB5951122DQ33686861-B46859F7-3D73-4F1E-8EEF-3C2986B3E07AQ34088575-A7BCC9A2-C6D7-44FD-98AD-8B4F7D9B2646Q34340985-119B555A-0A13-4FCD-B85C-F4CE33492771Q34480344-C3D1D091-9C1E-4532-BA84-BCD4AEEB2126Q35065456-ACFA7BAA-D681-4103-A4C0-408A75C2BBADQ35552815-C3990960-3BE6-469D-ADD7-D9165C1B6A1EQ35649161-D888866B-42C4-4706-9FA0-82ED5A44E719Q35667283-E7D43F5B-0413-435A-B7FD-AE322C7BBC18Q36173927-963E6708-C2A7-4877-B056-60A77F280AF4Q36188385-12FB86BD-DD0C-459D-BCD6-99FE64EAA0BDQ36293841-6288080B-BEF0-493A-A9EA-6942ADCCBEA6Q36783335-323517E7-16EB-4A38-A8C3-BA0FFF4D5769Q36847554-3998410E-794F-482F-85C9-2FF57796898BQ36954067-D318113E-DD93-4C19-9460-BC23CA9CC5C9Q37325876-231F4792-D628-4D9D-B7D1-23D25BBA3A04Q37340438-2C89B814-FAFB-4063-A6B1-588B99485194Q37504505-57E7D877-6E24-4B26-B5D9-778C7CDE7E48Q38107868-05301D6A-A433-4F7E-840D-91CCF7B9BD41Q38114375-0A49374E-3A00-4E40-9936-CCBBE03320B3Q38125511-B593AAB1-EE62-4E5C-87AF-6B040D554519Q38209384-2720737C-7903-4FD1-8977-396FFF7CC94CQ38427300-860B2A5D-EB5E-45F6-8F99-96CEDC096664Q38549770-F87EB6E6-C6CB-431F-821D-7564B80F6B83Q38760100-8A538167-A52E-4CB6-99CE-135293D1A97EQ41235376-01AE839D-7A6A-4B87-BD97-40A79BCDBA87Q43418239-472C713A-C0B5-42C0-B096-E00F7588AB94Q44274066-40882AFD-C7D0-4D66-AB8A-EC1FA4317429Q47618331-8EFE7855-B06A-4663-91F7-92E37AE58262Q47641657-8B06F50B-25DC-4FA6-8C76-6BEA2462FD05Q50146668-6EA42B20-9377-49B7-BB39-D897496ED93BQ50191785-09ED60CB-D545-4D12-BE44-5D04C6874753Q50624096-2EB03701-0595-4FA1-8B53-BC43FF5C7F75Q50693778-BCE8F4D8-D6C1-494B-8099-1B592BBDB57BQ50920332-D0E06B59-06BB-42DA-90A1-D8C25E748208Q51142138-67847FBD-84D3-41AD-9443-46152E72D272
P2860
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Trisomy 13 detection in the fi ...... cell-free DNA analysis method.
@en
Trisomy 13 detection in the fi ...... cell-free DNA analysis method.
@nl
type
label
Trisomy 13 detection in the fi ...... cell-free DNA analysis method.
@en
Trisomy 13 detection in the fi ...... cell-free DNA analysis method.
@nl
prefLabel
Trisomy 13 detection in the fi ...... cell-free DNA analysis method.
@en
Trisomy 13 detection in the fi ...... cell-free DNA analysis method.
@nl
P2093
P2860
P356
P1476
Trisomy 13 detection in the fi ...... cell-free DNA analysis method.
@en
P2093
P2860
P356
10.1002/UOG.12299
P577
2012-11-23T00:00:00Z